Current study also indicated that the tumor-promoting function of C1orf63 might not involve ER, PR or HER-2, as no significant correlation was observed between the expression of C1orf63 and these biomarkers in either breast cancer tissues or cell lines. This evidence concerns the gene PGR and breast cancer.